DNA Aptamer-Polymer Conjugates for Selective Targeting of Integrin α4β1+ T‑Lineage Cancers

Selective therapeutic targeting of T-cell malignancies is difficult due to the shared lineage between healthy and malignant T cells. Current front-line chemotherapy for these cancers is largely nonspecific, resulting in frequent cases of relapsed/refractory disease. The development of targeting appr...

Ausführliche Beschreibung